Angiography Catheters Market By Product (Scoring Balloon Catheters, Conventional Catheters, DEB Catheters, Cutting Balloon Catheters), By Application (ASCs, Hospitals, Clinics), & Region for 2024-2031

Angiography Catheters Market Valuation – 2024-2031

Rising prevalence of cardiovascular diseases globally, necessitating increased diagnostic and interventional procedures is propelling the adoption of angiography catheters. Increasing healthcare expenditure and improved healthcare infrastructure is enabling the market surpass USD 1.37 Billion valued in 2023 to reach a valuation of around USD 2.42 Billion by 2031.

In addition to this, expansion of minimally invasive surgical techniques, which often utilize angiography catheters is spurring up the adoption of angiography catheters. Supportive government initiatives and funding for cardiovascular disease management and treatment is enabling the market grow at a CAGR of 7.38% from 2024 to 2031.

Angiography Catheters MarketDefinition/ Overview

Angiography catheters are specialized medical devices used in angiography, a diagnostic imaging technique to visualize the inside of blood vessels and organs of the body, particularly the arteries, veins, and heart chambers. These catheters are thin, flexible tubes that are inserted into the blood vessels through a small incision and guided to the area of interest. A contrast dye is then injected through the catheter to enhance the visibility of the blood vessels under X-ray imaging, allowing for detailed examination and diagnosis of vascular conditions.

The primary application of angiography catheters is in the diagnosis and treatment of cardiovascular diseases. They are essential tools in procedures such as coronary angiography, peripheral angiography, cerebral angiography, and aortography. These procedures help in identifying blockages, aneurysms, and other vascular abnormalities. Angiography catheters are also used in interventional procedures like angioplasty and stent placement, where they facilitate the delivery of therapeutic devices to the targeted areas. The versatility and precision of angiography catheters make them indispensable in both diagnostic and therapeutic cardiovascular interventions.

Technological advancements and the increasing prevalence of cardiovascular diseases are driving the future scope of angiography catheters. Innovations in catheter design, advanced imaging techniques, and digital health technologies will enhance diagnostic accuracy and procedural outcomes. Emerging healthcare infrastructure and minimally invasive procedures will boost demand.

How will Rising Prevalence of Cardiovascular Diseases Increase Adoption of Angiography Catheters?

One of the primary drivers of the angiography catheters market is the increasing prevalence of cardiovascular diseases (CVDs) worldwide. Conditions such as coronary artery disease, peripheral artery disease, and stroke are becoming more common due to factors like aging populations, sedentary lifestyles, and unhealthy diets. This growing incidence necessitates more frequent diagnostic and interventional procedures, thereby driving the demand for angiography catheters.

Also, technological advancements in catheter design and imaging techniques are significantly propelling the market forward. Innovations such as improved catheter flexibility, smaller diameters for less invasive procedures, and enhanced imaging capabilities are making angiography more effective and safer for patients. These advancements not only improve patient outcomes but also increase the adoption of angiography procedures in medical practice, boosting market growth.

In addition to this, the global rise in the geriatric population is another crucial driver for the angiography catheters market. Older adults are more prone to cardiovascular conditions, which require regular monitoring and treatment. As the elderly population grows, so does the demand for diagnostic and therapeutic interventions involving angiography catheters, thereby expanding the market.

Furthermore, the expansion of healthcare infrastructure, especially in emerging markets, along with increased healthcare expenditure, is facilitating better access to advanced medical procedures, including angiography. Government initiatives and investments aimed at improving cardiovascular care and diagnostic facilities are enhancing the availability and adoption of angiography catheters. This trend is expected to continue, further driving the market growth as more healthcare providers adopt these technologies to meet the rising demand for cardiovascular diagnostics and treatments.

Will High Costs of Angiography Catheters Restrain Its Application?

One of the significant restraints of the angiography catheters market is the high cost associated with angiography procedures. The expense of advanced medical imaging technology, high-quality catheters, and the overall procedural costs can be prohibitive, especially in low and middle-income countries. This financial barrier limits the accessibility of angiography, reducing the potential market size and slowing growth, particularly in regions with constrained healthcare budgets.

Also, despite advancements in technology, angiography procedures carry inherent risks such as bleeding, infection, and adverse reactions to contrast dyes. These potential complications can deter both patients and healthcare providers from opting for angiography, preferring alternative diagnostic methods that may be perceived as safer. The fear of procedural risks and associated legal liabilities can act as a significant restraint on the market.

In addition to this, the increasing availability and advancement of alternative imaging techniques, such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA), pose a challenge to the angiography catheters market. These non-invasive imaging modalities offer high diagnostic accuracy without some of the risks associated with traditional catheter-based angiography. The growing preference for these alternatives can limit the demand for angiography catheters, restraining market expansion.

Category-Wise Acumens

Will Rise in Adoption of Conventional Catheters Drive Angiography Catheters Market?

Conventional catheters continue to dominate the angiography catheters market due to their widespread acceptance and long-standing use in medical practice. These catheters have established a strong track record of safety and efficacy, making them the go-to choice for many healthcare providers. Their proven reliability in various diagnostic and interventional procedures ensures their continued dominance, as clinicians are more comfortable and familiar with their use.

In addition to this, another reason for the dominance of conventional catheters is their cost-effectiveness and greater accessibility compared to newer, more advanced catheter technologies. Conventional catheters are generally less expensive to produce and purchase, making them more attractive to healthcare facilities, especially those with budget constraints. This cost advantage allows conventional catheters to maintain a significant share of the market, particularly in regions where healthcare resources are limited.

Also, despite being considered traditional, conventional catheters have not remained static. Continuous incremental innovations and improvements in materials, design, and manufacturing processes have enhanced their performance and safety profiles. These advancements have helped conventional catheters stay relevant and competitive in the market. Their ongoing evolution, combined with their established presence, ensures that conventional catheters remain a dominant force in the angiography catheters market.

 Which Factors Enhance the Use of Angiography Catheters in Hospitals?

Hospitals play a central role in the angiography catheters market due to their comprehensive cardiovascular care capabilities. As primary healthcare providers for severe and complex cardiovascular conditions, hospitals are equipped with the necessary infrastructure, technology, and specialized medical personnel to perform angiographic procedures. This makes them the predominant users of angiography catheters, as they conduct the majority of diagnostic and interventional cardiovascular procedures.

Furthermore, hospitals are typically equipped with advanced medical facilities and state-of-the-art equipment required for angiography, including catheterization labs and imaging systems. These facilities enable hospitals to efficiently perform high volumes of angiographic procedures, ensuring they maintain a significant share of the market. The presence of multidisciplinary teams and the ability to manage complications further reinforce hospitals’ dominance in utilizing angiography catheters.

In addition to this, hospitals handle a higher volume of patients, including those with complex and critical cardiovascular conditions that require detailed diagnostic imaging and interventional procedures. The ability to manage such high and diverse patient volumes, combined with their expertise in complex case management, positions hospitals as the primary consumers of angiography catheters. This dominance is also supported by the growing prevalence of cardiovascular diseases, which drives more patients to seek specialized care in hospital settings, thereby increasing the demand for angiography catheters.

Gain Access into Angiography Catheters Market Report Methodology

Country/Region Wise Acumens

Will High Prevalence of Cardiovascular Diseases in North America Mature Angiography Catheters Market?

North America is anticipated to dominate the angiography catheters market during the forecast period. The region has a high prevalence of cardiovascular diseases, which drives the demand for diagnostic and interventional procedures involving angiography catheters. Additionally, the presence of a well-established healthcare infrastructure, advanced medical facilities, and a significant number of specialized cardiac care centers contribute to this dominance.

Also, The market in North America benefits from rapid technological advancements and a strong focus on innovation. Companies in the U.S. and Canada are at the forefront of developing advanced angiography catheters with improved safety, efficacy, and patient comfort. These innovations, along with substantial investments in research and development, enhance the adoption of angiography catheters across various medical settings, further solidifying the region’s leading position.

In addition to this, the supportive regulatory environment in North America also plays a crucial role in market growth. Regulatory agencies like the FDA in the U.S. ensure stringent standards for product approval, ensuring high-quality and safe angiography catheters are available in the market. Furthermore, the region’s high healthcare expenditure allows for greater access to advanced medical technologies and procedures, enabling hospitals and clinics to adopt the latest angiography catheter solutions, thereby maintaining North America’s market dominance.

Will High Prevalence of Cardiovascular Diseases in North America Mature Angiography Catheters Market?

Europe is experiencing rapid growth in the angiography catheters market primarily due to the rising prevalence of cardiovascular diseases across the region. Countries like Germany, the U.K., and France are witnessing increasing cases of conditions such as coronary artery disease and stroke, driven by aging populations and lifestyle factors like poor diet and sedentary habits. This surge in cardiovascular health issues necessitates more frequent use of angiography catheters for both diagnostic and interventional procedures.

Also, the rapid growth of the angiography catheters market in Europe is also fueled by continuous advancements in healthcare infrastructure. European countries are investing heavily in upgrading their medical facilities and adopting state-of-the-art medical technologies. This includes the establishment of sophisticated catheterization labs and the incorporation of advanced imaging systems in hospitals and clinics. These improvements enable healthcare providers to perform a higher volume of angiographic procedures efficiently and effectively.

In addition to this, supportive government initiatives and favorable healthcare policies are significant contributors to the market’s rapid growth in Europe. Various national health programs and funding initiatives aimed at reducing the burden of cardiovascular diseases are promoting the adoption of advanced diagnostic tools like angiography catheters. Additionally, the emphasis on early diagnosis and preventive care, along with the presence of robust regulatory frameworks ensuring the quality and safety of medical devices, further accelerates the market expansion in the region.

Competitive Landscape

The competitive landscape of the angiography catheters market is characterized by intense rivalry among key players striving to maintain their foothold and gain market share. These players engage in strategies such as mergers and acquisitions, product innovations, and geographical expansions to strengthen their position in the market. Established companies leverage their extensive product portfolios, robust distribution networks, and strong brand recognition to retain customers and attract new ones. Additionally, technological advancements such as the development of advanced catheter materials, imaging technologies, and minimally invasive techniques drive competition by offering improved efficacy, safety, and patient outcomes. Emerging players focus on niche markets and innovative solutions to carve out their share of the market. Overall, the angiography catheters market is highly competitive, with companies vying for differentiation and competitive advantage through innovation, strategic partnerships, and customer-centric approaches.

Some of the prominent players operating in the angiography catheters market include

Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Johnson & Johnson (Cordis), Braun Melsungen AG, Koninklijke Philips N.V., Siemens Healthineers AG, Teleflex Incorporated, Merit Medical Systems, Inc., Cook Medical, Nipro Medical Corporation, AngioDynamics, Inc., Asahi Intecc Co., Ltd., Terumo Europe NV, Penumbra, Inc., BIOTRONIK SE & Co. KG, R. Bard, Inc. (acquired by BD), Endocor GmbH.

Latest Developments

• In June 2021, Abiomed has acquired preCARDIA, a proprietary catheter and controller developer, to expand its product portfolio for patients with ADHF.
• In March 2021, Catheter & Medical Design (CMD) has acquired VitalDyne Medical, a company specializing in precision technologies for minimally invasive devices, offering customers increased speed, flexibility, and value through product launches and expansions.

Report Scope

Angiography Catheters Market, By Category

Product

• Scoring Balloon Catheters
• Conventional Catheters
• DEB Catheters
• Cutting Balloon Catheters

Application

• ASCs
• Hospitals
• Clinics

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.